Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France

The purpose of this study is to describe the way candesartan is used in heart failure treatment in France (treatment initiation and monitoring), treatment stops occurrence and reasons for and patients clinical evolution

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Failure Cardiovascular Diseases Cohort Study Heart Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Mulhouse, Alsace, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

outpatients to whom candesartan has been initiated for less than 30 days or during the consultation to treat heart failure

Exclusion criteria

patients included in a clinical trial the last 30 days before consultation
patients unable to answer the questions for linguistic or cognitive reasons
patients who will be difficult to follow during the one year study

Treatment and study plan

Candesartan

Drug

Oral tablets

Other names: Atacand

Primary outcomes

Profile of patients treated with candesartan for heart failure

Time frame: At inclusion

Secondary outcomes

Percentage of patients taking correctly its treatment : indication, contraindication, drug titration, treatment monitoring

Time frame: 6 and 12 months after
Percentage of patients stopping its treatment and reasons why

Time frame: 12 months after
Percentage of hospitalisations due to heart failure and cardiovascular deaths

Time frame: 12 months after

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Collaborators

Takeda

Registry information

Acronym: SISTOLA

Important dates

Study start: 2008
Primary completion: 2010
Study completion: 2010
First posted: May 19, 2008
Registry last updated: Dec 2, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed